These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22497842)

  • 1. Treatment of COPD: no longer nihilism, but there is still an urgent need for new therapies.
    Matera MG; Cazzola M
    Curr Opin Pharmacol; 2012 Jun; 12(3):225-8. PubMed ID: 22497842
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological treatment of COPD. Where are we now?].
    Calle Rubio M; Pinedo Sierra C; Rodríguez Hermosa JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():3-7. PubMed ID: 21316549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping Before Starting Treatment in COPD?
    Siafakas N; Corlateanu A; Fouka E
    COPD; 2017 Jun; 14(3):367-374. PubMed ID: 28388265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute exacerbation of COPD].
    Bals R; Becker HF; Wagner U; Vogelmeier C
    Pneumologie; 2006 Jan; 60(1):11-23; quiz 24-5. PubMed ID: 16429389
    [No Abstract]   [Full Text] [Related]  

  • 5. [New drug therapy of chronic obstructive pulmonary disease].
    Kino H
    Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic obstructive pulmonary disease--traditional bronchodilatation and targeted anti-inflammatory therapy].
    Mróz RM; Skopiński T; Hołownia A; Chyczewska E; Braszko JJ
    Pneumonol Alergol Pol; 2011; 79(1):32-8. PubMed ID: 21190151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical profile of roflumilast].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():25-32. PubMed ID: 21316553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of combining inhaled drugs for COPD.
    Bjerg A; Lundbäck B; Lötvall J
    Curr Opin Pharmacol; 2012 Jun; 12(3):252-5. PubMed ID: 22465638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for chronic obstructive pulmonary disease.
    Matera MG; Calzetta L; Segreti A; Cazzola M
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):61-82. PubMed ID: 22335427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating systemic effects of COPD.
    Cazzola M; Matera MG; Rogliani P; Page C
    Trends Pharmacol Sci; 2007 Oct; 28(10):544-50. PubMed ID: 17897727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Limitations of current treatment: unmet needs in the treatment of COPD].
    de Lucas Ramos P; López Martín S; Rodríguez González-Moro JM
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():8-13. PubMed ID: 21316550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD: is there light at the end of the tunnel?
    Barnes PJ
    Curr Opin Pharmacol; 2004 Jun; 4(3):263-72. PubMed ID: 15140418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathology of COPD: choosing the right therapeutic targets].
    Devillier P
    Rev Pneumol Clin; 2003 Apr; 59(2 Pt 2):S6-10. PubMed ID: 12966779
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft drugs for future treatment of chronic obstructive pulmonary disease (COPD).
    Szelenyi I
    Pharmazie; 2012 May; 67(5):371-3. PubMed ID: 22764565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel therapeutics for COPD].
    Hoshino Y; Muro S; Mishima M
    Nihon Rinsho; 2011 Oct; 69(10):1826-30. PubMed ID: 22073581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toward personalized and integrated treatment of patients with COPD].
    Ancochea J; Gómez García T; de Miguel Díez J
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.